Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - sitagliptin hydrochloride monohydrate 113,37 mg - eq. sitagliptin 100 mg - film-coated tablet - 100 mg - sitagliptin hydrochloride monohydrate 113.37 mg - sitagliptin

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

joint stock company grindeks - sitagliptin hydrochloride monohydrate 28,35 mg - eq. sitagliptin 25 mg - film-coated tablet - 25 mg - sitagliptin hydrochloride monohydrate 28.35 mg - sitagliptin

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

joint stock company grindeks - sitagliptin hydrochloride monohydrate 56,7 mg - eq. sitagliptin 50 mg - film-coated tablet - 50 mg - sitagliptin hydrochloride monohydrate 56.7 mg - sitagliptin

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

joint stock company grindeks - sitagliptin hydrochloride monohydrate 113,4 mg - eq. sitagliptin 100 mg - film-coated tablet - 100 mg - sitagliptin hydrochloride monohydrate 113.4 mg - sitagliptin

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - sitagliptin hydrochloride monohydrate 28,34 mg - eq. sitagliptin 25 mg - film-coated tablet - 25 mg - sitagliptin hydrochloride monohydrate 28.34 mg - sitagliptin

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - sitagliptin hydrochloride monohydrate 56,69 mg - eq. sitagliptin 50 mg - film-coated tablet - 50 mg - sitagliptin hydrochloride monohydrate 56.69 mg - sitagliptin

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - sitagliptin hydrochloride monohydrate 113,38 mg - eq. sitagliptin 100 mg - film-coated tablet - 100 mg - sitagliptin hydrochloride monohydrate 113.38 mg - sitagliptin

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 64.25 mg; metformin hydrochloride, quantity: 1000 mg - tablet - excipient ingredients: microcrystalline cellulose; sodium lauryl sulfate; sodium stearylfumarate; povidone; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - janumet (sitagliptin phosphate monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.,[see sections 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration].

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 64.25 mg; metformin hydrochloride, quantity: 500 mg - tablet - excipient ingredients: povidone; microcrystalline cellulose; sodium stearylfumarate; sodium lauryl sulfate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - janumet (sitagliptin phosphate monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.,[see sections 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration].

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

as grindeks - metformin hydrochloride; sitagliptin hydrochloride monohydrate - film-coated tablet - metformin and sitagliptin